|
End-of-day quote
NYSE
2026-09-04
|
5-day change | 1st Jan Change | ||
| 6.190 USD | +25.18% |
|
+29.50% | -15.32% |
| Fiscal Period: December | 2024 (USD) | 2025 (USD) |
|---|---|---|
Profitability | ||
Return on Assets | - | -25.84 |
Return on Total Capital | - | -37.03 |
Return On Equity % | - | -84.01 |
Return on Common Equity | - | 37.77 |
Margin Analysis | ||
Gross Profit Margin % | 14.7 | 19.71 |
SG&A Margin | 52.58 | 75.86 |
EBITDA Margin % | -81.64 | -103.42 |
EBITA Margin % | -83.94 | -105.51 |
EBIT Margin % | -85.53 | -107.37 |
Income From Continuing Operations Margin % | -105.46 | -136.09 |
Net Income Margin % | -105.46 | -136.09 |
Net Avail. For Common Margin % | -112.89 | -141.06 |
Normalized Net Income Margin | -65.78 | -80.37 |
Levered Free Cash Flow Margin | - | -50.07 |
Unlevered Free Cash Flow Margin | - | -49.69 |
Asset Turnover | ||
Asset Turnover | - | 0.39 |
Fixed Assets Turnover | - | 4.43 |
Receivables Turnover (Average Receivables) | - | 2.17 |
Inventory Turnover (Average Inventory) | - | 3.49 |
Short Term Liquidity | ||
Current Ratio | 2.42 | 3.34 |
Quick Ratio | 1.9 | 2.77 |
Operating Cash Flow to Current Liabilities | -1.52 | -1.53 |
Days Sales Outstanding (Average Receivables) | - | 167.88 |
Days Outstanding Inventory (Average Inventory) | - | 104.58 |
Average Days Payable Outstanding | - | 40.42 |
Cash Conversion Cycle (Average Days) | - | 232.04 |
Long Term Solvency | ||
Total Debt/Equity | 24.02 | 8.59 |
Total Debt / Total Capital | 19.37 | 7.91 |
LT Debt/Equity | 9.2 | 5.52 |
Long-Term Debt / Total Capital | 7.42 | 5.08 |
Total Liabilities / Total Assets | 55.93 | 29.76 |
EBIT / Interest Expense | -31.71 | -179.38 |
EBITDA / Interest Expense | -28.37 | -163.12 |
(EBITDA - Capex) / Interest Expense | -29.36 | -165.93 |
Total Debt / EBITDA | -0.26 | -0.22 |
Net Debt / EBITDA | 0.52 | 1.15 |
Total Debt / (EBITDA - Capex) | -0.25 | -0.22 |
Net Debt / (EBITDA - Capex) | 0.5 | 1.13 |
Growth Over Prior Year | ||
Total Revenues, 1 Yr. Growth % | - | 20.6 |
Gross Profit, 1 Yr. Growth % | - | 61.71 |
EBITDA, 1 Yr. Growth % | - | 52.78 |
EBITA, 1 Yr. Growth % | - | 51.6 |
EBIT, 1 Yr. Growth % | - | 51.39 |
Earnings From Cont. Operations, 1 Yr. Growth % | - | 55.61 |
Net Income, 1 Yr. Growth % | - | 55.61 |
Normalized Net Income, 1 Yr. Growth % | - | 47.35 |
Diluted EPS Before Extra, 1 Yr. Growth % | - | 40.53 |
Accounts Receivable, 1 Yr. Growth % | - | -2.41 |
Inventory, 1 Yr. Growth % | - | 3.87 |
Net Property, Plant and Equip., 1 Yr. Growth % | - | 75.38 |
Total Assets, 1 Yr. Growth % | - | 132.58 |
Tangible Book Value, 1 Yr. Growth % | - | 64.65 |
Common Equity, 1 Yr. Growth % | - | 36.56 |
Cash From Operations, 1 Yr. Growth % | - | 30.01 |
Capital Expenditures, 1 Yr. Growth % | - | -24.55 |
- Stock Market
- Stocks
- XTND Stock
- Financials Xtend AI Robotics, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
















